Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Aceragen, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 31 | 33 | +2 |
| Shares | 3.73M | 3.60M | −130.5K (−3.5%) |
| Value | $1.86M | $1.65M | −$214.0K (−11.5%) |
New holders (5)
Institutions that held Aceragen, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Credit Agricole S A | 200,000 | $92.0K | 0.00% |
| Millennium Management LLC | 122,238 | $56.0K | 0.00% |
| Renaissance Technologies LLC | 31,500 | $14.0K | 0.00% |
| Citigroup Inc | 14,293 | $7.00K | 0.00% |
| Two Sigma Securities, LLC | 13,907 | $6.00K | 0.00% |
Sold out (3)
Institutions that held Aceragen, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Acadian Asset Management LLC | 457,100 | $228.0K |
| Susquehanna International Group, LLP | 19,699 | $10.0K |
| Federated Hermes, Inc. | 1,870 | $1.00K |